Description
F-peptide binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
F-peptide binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Cas No. | 71901-21-8 |
|---|---|
| Purity | ≥95% |
| Formula | C43H65O7N9 |
| Formula Wt. | 824.04 |
| IUPAC Name | 6-amino-2-[[2-[2-[[2-[[2-(2-formamidohexanoylamino)-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]hexanoylamino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoic acid |
| Synonym | F-Chemotactic peptide, F-Peptide, N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys |
| Solubility | Soluble in methanol/acetic acid 1:1 (1 mg/mL). |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Allen RA, Erickson RW, Jesaitis AJ. Identification of a human neutrophil protein of Mr 24 000 that binds N-formyl peptides: co-sedimentation with specific granules. Biochim Biophys Acta. 1989 Apr 25;991(1):123-33. PMID: 2653446.
Bisphosphonate; inhibits transfer of farnesyl p...
SERM.
Prolyl hydroxylase inhibitor.
ATR inhibitor.
Histamine H1 antagonist.
Inhibitor of EGFR, HER2, VEGFR2, and FLT3.
Akt inhibitor.
FAAH inhibitor.
Xanthine oxidase inhibitor.
Endogenous peptide, produced by activation of P...
PERK inhibitor.
Phenothiazine; D1/2 and α1-adrenergic antagoni...
Synthesis impurity
Sulfonylurea; ATP-sensitive K+ channel blocker....
Topoisomerase II inhibitor, RPA modulator.
Glucocorticoid agonist.
Endogenous sphingosine-based lipid, component o...
Endogenous peptide hormone, glugagon fragment; ...
Macrolide; F1F0 ATP synthase inhibitor.
Mesalazine derivative, sulfa drug; sepiapterin ...